145 related articles for article (PubMed ID: 25941919)
1. Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect.
Misailidis G; Ragia G; Ivanova DD; Tavridou A; Manolopoulos VG
Drug Metab Pers Ther; 2015 Jun; 30(2):129-35. PubMed ID: 25941919
[TBL] [Abstract][Full Text] [Related]
2. Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence.
Ragia G; Veresies I; Veresie L; Veresies K; Manolopoulos VG
Drug Metab Pers Ther; 2016 Sep; 31(3):143-50. PubMed ID: 27447243
[TBL] [Abstract][Full Text] [Related]
3. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.
Ray R; Jepson C; Patterson F; Strasser A; Rukstalis M; Perkins K; Lynch KG; O'Malley S; Berrettini WH; Lerman C
Psychopharmacology (Berl); 2006 Oct; 188(3):355-63. PubMed ID: 16960700
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder.
Hirasawa-Fujita M; Bly MJ; Ellingrod VL; Dalack GW; Domino EF
Clin Schizophr Relat Psychoses; 2017; 11(1):39-48. PubMed ID: 28548579
[TBL] [Abstract][Full Text] [Related]
5. Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes.
Kleinjan M; Engels RC; DiFranza JR
BMC Pulm Med; 2015 Oct; 15():115. PubMed ID: 26449981
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation.
Verhagen M; Kleinjan M; Engels RC
Pharmacogenomics; 2012 Jun; 13(8):917-33. PubMed ID: 22676196
[TBL] [Abstract][Full Text] [Related]
7. Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex.
Kleinjan M; Poelen EA; Engels RC; Verhagen M
Addict Biol; 2013 Nov; 18(6):1003-12. PubMed ID: 22260295
[TBL] [Abstract][Full Text] [Related]
8. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
9. Initial responses to the first dose of nicotine in novel smokers: the role of exposure to environmental smoking and genetic predisposition.
Schuck K; Otten R; Engels RC; Kleinjan M
Psychol Health; 2014; 29(6):698-716. PubMed ID: 24446757
[TBL] [Abstract][Full Text] [Related]
10. Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism.
Domino EF; Evans CL; Ni L; Guthrie SK; Koeppe RA; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):236-40. PubMed ID: 22516252
[TBL] [Abstract][Full Text] [Related]
11. Association of the mu-opioid receptor gene with smoking cessation.
Munafò MR; Elliot KM; Murphy MF; Walton RT; Johnstone EC
Pharmacogenomics J; 2007 Oct; 7(5):353-61. PubMed ID: 17224915
[TBL] [Abstract][Full Text] [Related]
12. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.
Bart G; Kreek MJ; Ott J; LaForge KS; Proudnikov D; Pollak L; Heilig M
Neuropsychopharmacology; 2005 Feb; 30(2):417-22. PubMed ID: 15525999
[TBL] [Abstract][Full Text] [Related]
13. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
[TBL] [Abstract][Full Text] [Related]
14. Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population.
Nishizawa D; Han W; Hasegawa J; Ishida T; Numata Y; Sato T; Kawai A; Ikeda K
Neuropsychobiology; 2006; 53(3):137-41. PubMed ID: 16679777
[TBL] [Abstract][Full Text] [Related]
15. Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.
Liu YC; Wang WS
Cancer; 2012 Mar; 118(6):1718-25. PubMed ID: 21837673
[TBL] [Abstract][Full Text] [Related]
16. Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphism.
Sander T; Hildmann T; Kretz R; Fürst R; Sailer U; Bauer G; Schmitz B; Beck-Mannagetta G; Wienker TF; Janz D
Am J Med Genet; 1997 Jul; 74(4):416-21. PubMed ID: 9259378
[TBL] [Abstract][Full Text] [Related]
17. Lack of association of OPRM1 genotype and smoking cessation.
Munafò MR; Johnstone EC; Aveyard P; Marteau T
Nicotine Tob Res; 2013 Mar; 15(3):739-44. PubMed ID: 22990223
[TBL] [Abstract][Full Text] [Related]
18. Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers.
Weerts EM; Wand GS; Maher B; Xu X; Stephens MA; Yang X; McCaul ME
Alcohol Clin Exp Res; 2017 Jun; 41(6):1093-1104. PubMed ID: 28376280
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
20. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
Kumar D; Chakraborty J; Das S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
